CDX Research, page-86

  1. 507 Posts.
    lightbulb Created with Sketch. 333

    Launch of 8 new devices and associated software/ digital solutions coming into the market in 2020 & 2021 with a great CEO at the helm with novel products in a new and exciting space.


    Just look below slide from the recent presso. In my opinion once the news flows start streaming in through out 2020 and 2021. Cardiex should re-rate considerably.

    “The medical/home-use market is forecast to be worth $US2.5bn in 2025 by Fortune Business Insights.”

    Medical and consumer wearables is seen to touch $US37bn by 2025, by Industry Stats Report, which CardieX is accessing via partnerships with industry luminaries like Blumio and Mobvoi for a smartwatch.”

    “And finally, there’s the software-as-a-service (SaaS) opportunity, forecast at $US509bn by Grand View Research and including the company’s ARTY cloud-based digital hub, clinician portal and consumer app.”

    https://hotcopper.com.au/data/attachments/2405/2405910-ba466170d9b8d9e4d0c7acc1b28794ec.jpg

    All in my opinion. Good luck to all.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
4.0¢
Change
0.000(0.00%)
Mkt cap ! $17.49M
Open High Low Value Volume
3.9¢ 4.0¢ 3.8¢ $15.72K 411.6K

Buyers (Bids)

No. Vol. Price($)
3 82141 3.8¢
 

Sellers (Offers)

Price($) Vol. No.
4.2¢ 158194 2
View Market Depth
Last trade - 13.12pm 27/06/2025 (20 minute delay) ?
CDX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.